Source: Guardian Unlimited - UK
Date: May 8, 2007
Summary:
Advanced Cell Technology (ACT), a biotechnology company in the field of stem cell research, has applied for permission from US authorities to begin trials on humans of a new stem cell technique that it says holds out the promise of rapid healing of damaged eyes, lungs, hearts and arteries. The company announced it had devised a simple method for taking stem cells from human embryos and turning them into the precursor cells of blood vessels. Injected into mice and rats, the researchers found that the cells migrated to damaged parts of the body and helped to repair them.
